Keyword: National Institute for Health and Clinical Excellence
News
01.11.2012
- Medical journal The Lancet warned that Sanofi's experimental multiple sclerosis drug Lemtrada may be too costly for patients and health insurers once it gets approved by regulators...
News
16.05.2012
- Britain's drug watchdog has reversed a controversial decision not to fund a new prostate cancer pill that was developed in the country after maker Johnson & Johnson agreed a new...
News
22.06.2010
- The European Medicines Agency (EMA) may in future decide not only if new drugs should be licensed for use but also whether one medicine is better than another. The idea of giving...
